Scientists from Singapore have streamlined the process of using human stem cells to mass produce GABAergic neurons (GNs) in the laboratory. This new protocol provides scientists with a robust source of GNs to study many psychiatric and neurological disorders such as autism, schizophrenia, and epilepsy, which are thought to develop at least in part due to GN dysfunction.
GNs are inhibitory neurons that reduce neuronal activation, and make up roughly 20 per cent of the human brain. They work alongside excitatory neurons (ENs) to ensure balanced neural activity for normal brain function. The coordinated interplay between GNs and ENs orchestrate specific activation patterns in the brain, which are responsible for our behavior, emotions, and higher reasoning. Functional impairment of GNs results in imbalanced neural activity, thereby contributing to the symptoms observed in many psychiatric disorders.
The availability of high quality, functional human GN populations would facilitate the development of good models for studying psychiatric disorders, as well as for screening drug effects on specific populations of neurons. Scientists worldwide have been hard at work trying to generate a consistent supply of GNs in the laboratory, but have been faced with many challenges. Protocols involving multiple complex stages, poor yield, and requiring a long time to generate mature and functional GNs are just some of the limitations encountered.
Many of these limitations have now been overcome by the development of a rapid and robust protocol to generate GNs from human pluripotent stem cells (hPSCs) in a single step. With the addition of a specific combination of factors, hPSCs turn into mature and functional GNs in a mere six -- eight weeks. This is about two -- three times faster than the 10 - 30 weeks required for previous protocols. In addition, this new protocol is highly efficient, with GNs making up more than 80 per cent of the final neuron population.
To develop this protocol, the team first identified genetic factors involved in GN development in the brain. The team then tried many different combinations of these factors, and succeeded in confirming that mature and functional human GNs were indeed generated.
"Just like how a balance of Yin and Yang is needed in order to stay healthy, a balance of ENs and GNs is required for normal brain function. We now know a fair bit about ENs because we have good protocols to make them. However, we still know very little of the other player, the GNs, because current protocols do not work well. Yet, when these GNs malfunction our brain goes haywire," commented co-first author of the publication published in the journal Cell Reports.
"Our quick, efficient and easy way to mass produce GNs for lab use is a game changer for neuroscience and drug discovery. With increased recognition of the essential role of GNs in almost all neurological and psychiatric diseases, we envisage our new method to be widely used to advance research and drug screening," said senior author of the study.
The speed and efficiency of generating GNs with this new protocol provides researchers unprecedented access to the quantities of neurons necessary for studying the role of GNs in disease mechanisms. Drugs and small molecules may now be screened at an unparalleled rate to discover the next blockbuster treatment for autism, schizophrenia, and epilepsy.
http://www.cell.com/cell-reports/abstract/S2211-1247(16)30953-6
Mass produce human neurons for studying neuropsychiatric disorders
- 1,818 views
- Added
Edited
Latest News
Key mechanism controlling skin regeneration
Dynamic control of visually guided locomotion through corticosubthalamic projections
Vitamin K cycle is a potent ferroptosis suppressor
Cool room temperature inhibited cancer growth in mice
α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
Other Top Stories
Radiologists and AI Together Better at Detecting Breast Cancer
Stomach glial cells play a crucial role in intestinal tumor growth
Histone lactylation and cancer!
Patterns of genetic changes in healthy colon tissue provides insight into the very earliest stages of cancer
A novel tumor suppressor mutation linked to human gastrointestinal stromal tumors
Protocols
An improved organotypic cell culture system to study tissue-resident macrophages ex vivo
Protocol for spike-triggered closed-loop auditory stimulation during sleep in patients with epilepsy
Spectral fiber photometry derives hemoglobin concentration changes for accurate measurement of fl…
A Microengineered Brain-Chip to Model Neuroinflammation in Humans
A paper-based assay for the colorimetric detection of SARS-CoV-2 variants at single-nucleotide re…
Publications
Glioblastoma hijacks neuronal mechanisms for brain invasion
Gut commensals expand vitamin A metabolic capacity of the mammalian host
A sphingolipid-mTORC1 nutrient-sensing pathway regulates animal development by an intestinal pero…
CDK9 activity switch associated with AFF1 and HEXIM1 controls differentiation initiation from ep…
Store-operated calcium entry is reduced in spastin-linked hereditary spastic paraplegia
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER